{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T02:21:49Z","timestamp":1785378109889,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2111,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1038\/labinvest.2016.141","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T08:42:16Z","timestamp":1483951336000},"page":"458-467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Pathogenic role of endogenous TNF-\u03b1 in the development of Sj\u00f6gren's-like sialadenitis and secretory dysfunction in non-obese diabetic mice"],"prefix":"10.1016","volume":"97","author":[{"given":"Jing","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihisa","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.2016.141_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00005-009-0002-4","article-title":"Sjogren's syndrome: an old tale with a new twist","volume":"57","author":"Lee","year":"2009","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1038\/labinvest.2016.141_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1196\/annals.1384.003","article-title":"Autoimmune diseases and Sjogren's syndrome: an autoimmune exocrinopathy","volume":"1098","author":"Fox","year":"2007","journal-title":"Ann NY Acad Sci"},{"key":"10.1038\/labinvest.2016.141_bib3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrrheum.2010.118","article-title":"Pathogenetic mechanisms in the initiation and perpetuation of Sjogren's syndrome","volume":"6","author":"Voulgarelis","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1038\/labinvest.2016.141_bib4","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/art.20176","article-title":"Mortality and causes of death in primary Sjogren's syndrome: a prospective cohort study","volume":"50","author":"Theander","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1038\/labinvest.2016.141_bib5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jaut.2012.05.019","article-title":"The T cell in Sjogren's syndrome: force majeure, not spectateur","volume":"39","author":"Singh","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1038\/labinvest.2016.141_bib6","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.immuni.2004.08.013","article-title":"A T cell intrinsic role of Id3 in a mouse model for primary Sjogren's syndrome","volume":"21","author":"Li","year":"2004","journal-title":"Immunity"},{"key":"10.1038\/labinvest.2016.141_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/ar3348","article-title":"Disturbance of cytokine networks in Sjogren's syndrome","volume":"13","author":"Youinou","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1038\/labinvest.2016.141_bib8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12016-007-8011-8","article-title":"T lymphocytes in Sjogren's syndrome: contributors to and regulators of pathophysiology","volume":"32","author":"Katsifis","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1038\/labinvest.2016.141_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2567.2007.02614.x","article-title":"B-lymphocyte depletion ameliorates Sjogren's syndrome in Id3 knockout mice","volume":"122","author":"Hayakawa","year":"2007","journal-title":"Immunology"},{"key":"10.1038\/labinvest.2016.141_bib10","first-page":"11742","article-title":"T cell-associated cytokines in the pathogenesis of Sjogren's syndrome","volume":"S1","author":"Jin","year":"2013","journal-title":"J Clin Cell Immunol"},{"key":"10.1038\/labinvest.2016.141_bib11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/0022034513483315","article-title":"Type I interferon receptor deficiency prevents murine Sjogren's syndrome","volume":"92","author":"Szczerba","year":"2013","journal-title":"J Dent Res"},{"key":"10.1038\/labinvest.2016.141_bib12","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1136\/ard.2009.115378","article-title":"Cytokines in Sjogren's syndrome: potential therapeutic targets","volume":"69","author":"Roescher","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/labinvest.2016.141_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-3083.2001.00958.x","article-title":"IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD.IL-4-gene knockout mouse model of Sjogren's syndrome","volume":"54","author":"Brayer","year":"2001","journal-title":"Scand J Immunol"},{"key":"10.1038\/labinvest.2016.141_bib14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.0300-9475.2004.01508.x","article-title":"A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse","volume":"60","author":"Cha","year":"2004","journal-title":"Scand J Immunol"},{"key":"10.1038\/labinvest.2016.141_bib15","doi-asserted-by":"crossref","first-page":"R220","DOI":"10.1186\/ar3207","article-title":"Pathogenic effect of interleukin-17A in induction of Sjogren's syndrome-like disease using adenovirus-mediated gene transfer","volume":"12","author":"Nguyen","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1038\/labinvest.2016.141_bib16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/labinvest.2010.164","article-title":"IL17: potential therapeutic target in Sjogren's syndrome using adenovirus-mediated gene transfer","volume":"91","author":"Nguyen","year":"2011","journal-title":"Lab Invest"},{"key":"10.1038\/labinvest.2016.141_bib17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/rheumatology\/41.3.329","article-title":"The role of TNF-alpha in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): a study using a human RA\/SCID mouse chimera","volume":"41","author":"Matsuno","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1038\/labinvest.2016.141_bib18","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/ard.61.4.298","article-title":"Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors","volume":"61","author":"Mease","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/labinvest.2016.141_bib19","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ncpgasthep0528","article-title":"Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis","volume":"3","author":"Sartor","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1038\/labinvest.2016.141_bib20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.immunol.19.1.163","article-title":"Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?","volume":"19","author":"Feldmann","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1038\/labinvest.2016.141_bib21","first-page":"970","article-title":"Salivary cytokine profiles in primary Sjogren's syndrome differ from those in non-Sjogren sicca in terms of TNF-alpha levels and Th-1\/Th-2 ratios","volume":"29","author":"Kang","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1038\/labinvest.2016.141_bib22","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.4049\/jimmunol.152.11.5532","article-title":"Cytokine mRNA expression in salivary gland biopsies of Sjogren's syndrome","volume":"152","author":"Fox","year":"1994","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.2016.141_bib23","doi-asserted-by":"crossref","first-page":"e000282","DOI":"10.1136\/rmdopen-2016-000282","article-title":"Fatigue in primary Sjogren's syndrome is associated with lower levels of proinflammatory cytokines","volume":"2","author":"Howard Tripp","year":"2016","journal-title":"RMD Open"},{"key":"10.1038\/labinvest.2016.141_bib24","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/art.39629","article-title":"Association of increased Treg cell levels with elevated indoleamine 2,3-dioxygenase activity and an imbalanced kynurenine pathway in interferon-positive primary Sjogren's syndrome","volume":"68","author":"Maria","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1038\/labinvest.2016.141_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1067\/mlc.2002.120648","article-title":"Regulation of apoptotic cell death by cytokines in a human salivary gland cell line: distinct and synergistic mechanisms in apoptosis induced by tumor necrosis factor alpha and interferon gamma","volume":"139","author":"Kamachi","year":"2002","journal-title":"J Lab Clin Med"},{"key":"10.1038\/labinvest.2016.141_bib26","doi-asserted-by":"crossref","first-page":"C1191","DOI":"10.1152\/ajpcell.00144.2008","article-title":"Proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma alter tight junction structure and function in the rat parotid gland Par-C10 cell line","volume":"295","author":"Baker","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1038\/labinvest.2016.141_bib27","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/ard.54.11.904","article-title":"Enhanced membrane expression of the 52 kDa Ro(SS-A) and La(SS-B) antigens by human keratinocytes induced by TNF alpha","volume":"54","author":"Dorner","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/labinvest.2016.141_bib28","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1073\/pnas.1601992113","article-title":"Aquaporin gene therapy corrects Sjogren's syndrome phenotype in mice","volume":"113","author":"Lai","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/labinvest.2016.141_bib29","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1159\/000088179","article-title":"A mouse caries model and evaluation of aqp5-\/- knockout mice","volume":"39","author":"Culp","year":"2005","journal-title":"Caries Res"},{"key":"10.1038\/labinvest.2016.141_bib30","doi-asserted-by":"crossref","first-page":"20071","DOI":"10.1074\/jbc.274.29.20071","article-title":"Defective secretion of saliva in transgenic mice lacking aquaporin-5 water channels","volume":"274","author":"Ma","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2016.141_bib31","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1111\/j.1582-4934.2011.01456.x","article-title":"TNF-alpha inhibits aquaporin 5 expression in human salivary gland acinar cells via suppression of histone H4 acetylation","volume":"16","author":"Yamamura","year":"2012","journal-title":"J Cell Mol Med"},{"key":"10.1038\/labinvest.2016.141_bib32","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1002\/1529-0131(200110)44:10<2371::AID-ART401>3.0.CO;2-W","article-title":"Infliximab in patients with primary Sjogren's syndrome: a pilot study","volume":"44","author":"Steinfeld","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1038\/labinvest.2016.141_bib33","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/art.20146","article-title":"Inefficacy of infliximab in primary Sjogren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjogren's Syndrome (TRIPSS)","volume":"50","author":"Mariette","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1038\/labinvest.2016.141_bib34","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/art.27362","article-title":"Disruption of tight junction structure in salivary glands from Sjogren's syndrome patients is linked to proinflammatory cytokine exposure","volume":"62","author":"Ewert","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1038\/labinvest.2016.141_bib35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jaut.2013.12.012","article-title":"The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjogren's syndrome: a critical review","volume":"51","author":"Sumida","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1038\/labinvest.2016.141_bib36","first-page":"296","article-title":"Muscarinic acetylcholine type-3 receptor desensitization due to chronic exposure to Sjogren's syndrome-associated autoantibodies","volume":"33","author":"Cha","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1038\/labinvest.2016.141_bib37","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jaut.2010.08.004","article-title":"Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjogren's syndrome-like sialoadenitis","volume":"35","author":"Iizuka","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1038\/labinvest.2016.141_bib38","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/ar2341","article-title":"The role of tumor necrosis factor-alpha in systemic lupus erythematosus","volume":"10","author":"Aringer","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1038\/labinvest.2016.141_bib39","first-page":"S403","article-title":"Treatment with pegylated recombinant methionyl human soluble tumor necrosis factor-type 1 receptor prevents development of Sj\u00f6gren's syndrome and diabetes in the NOD mouse model","volume":"42","author":"Tornwald","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1038\/labinvest.2016.141_bib40","doi-asserted-by":"crossref","first-page":"R189","DOI":"10.1186\/ar2888","article-title":"Local expression of tumor necrosis factor-receptor 1:immunoglobulin G can induce salivary gland dysfunction in a murine model of Sjogren's syndrome","volume":"11","author":"Vosters","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1038\/labinvest.2016.141_bib41","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1471-4159.2010.07124.x","article-title":"Fas ligation and tumor necrosis factor alpha activation of murine astrocytes promote heat shock factor-1 activation and heat shock protein expression leading to chemokine induction and cell survival","volume":"116","author":"Choi","year":"2011","journal-title":"J Neurochem"},{"key":"10.1038\/labinvest.2016.141_bib42","doi-asserted-by":"crossref","first-page":"6846","DOI":"10.4049\/jimmunol.172.11.6846","article-title":"TNF influences chemokine expression of macrophages in vitro and that of CD11b+ cells in vivo during Mycobacterium tuberculosis infection","volume":"172","author":"Algood","year":"2004","journal-title":"J Immunol"},{"key":"10.1038\/labinvest.2016.141_bib43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/icb.2010.158","article-title":"CXCR3 ligands: redundant, collaborative and antagonistic functions","volume":"89","author":"Groom","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"10.1038\/labinvest.2016.141_bib44","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1189\/jlb.0113036","article-title":"CXCL13 is elevated in Sjogren's syndrome in mice and humans and is implicated in disease pathogenesis","volume":"94","author":"Kramer","year":"2013","journal-title":"J Leukoc Biol"},{"key":"10.1038\/labinvest.2016.141_bib45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13075-016-0995-0","article-title":"Baseline CXCL10 and CXCL13 levels are predictive biomarkers for tumor necrosis factor inhibitor therapy in patients with moderate to severe rheumatoid arthritis: a pilot, prospective study","volume":"18","author":"Han","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1038\/labinvest.2016.141_bib46","doi-asserted-by":"crossref","unstructured":"Baker OJ . Tight junctions in salivary epithelium. J Biomed Biotechnol 2010 2010; 278948.","DOI":"10.1155\/2010\/278948"},{"key":"10.1038\/labinvest.2016.141_bib47","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1874312901206010315","article-title":"Anti-tumor necrosis factor-alpha induced systemic lupus erythematosus","volume":"6","author":"Almoallim","year":"2012","journal-title":"Open Rheumatol J"},{"key":"10.1038\/labinvest.2016.141_bib48","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/art.22327","article-title":"Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus","volume":"56","author":"Aringer","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1038\/labinvest.2016.141_bib49","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1002\/art.20576","article-title":"Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study","volume":"50","author":"Aringer","year":"2004","journal-title":"Arthritis Rheum"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/labinvest2016141.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest2016141","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722011709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722011709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest2016141.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:36:01Z","timestamp":1758396961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722011709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0023683722011709"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.2016.141","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenic role of endogenous TNF-\u03b1 in the development of Sj\u00f6gren's-like sialadenitis and secretory dysfunction in non-obese diabetic mice","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2016.141","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}